#Lichen_Planus
Lichen planus is an idiopathic
papulosquamous disorder characterized by
itchy pink to purple papules and plaques, occurring primarily on the scalp, extremities, nails, and mucous membranes.
History
■ Most patients develop the disorder between
30 and 60 years of age.
■ Lichen planus is rare in children younger than 5 years and in elderly people.
■ Up to 10% of patients have a family history of lichen planus.
■ Most patients with cutaneous disease show evidence of mucosal involvement
■ The cause is unknown, but lichen planus may be a T-cell−driven autoimmune disease.
■ Lichen planus may be associated with
hepatitis C and many medications.
Skin Findings
■ The primary lesion is a 2- to 10-mm
flat-topped papule with an irregular,
angulated border (purple polygonal papules).
■ New lesions are pink to white, but over time they become purple and sharply defined.
■ Surface shows a lacy reticulated pattern of whitish lines (Wickham’s striae).
■ New lesions may develop in areas of injury (Koebner’s phenomenon).
■ There are several clinical form
Treatment:-
■ Sedating antihistamines (hydroxyzine 10–25 mg every 4 hours) are effective to control itch.
■ Group I or II topical glucocorticoids are
required to control lichen planus.
■ Intralesional triamcinolone acetonide
(Kenalog 5–10 mg/mL) is very effective for thicker plaques.
■ For oral lichen planus, high-potency
glucocorticoid (ointments or orabase) and
tacrolimus applied twice daily are effective to control inflammation.
■ Narrow-band ultraviolet B should be
considered for widespread lichen planus.
■ Systemic glucocorticoids, methotrexate, cyclosporine, and mycophenolate mofetil should be considered for severe lichen planus.
Source :- https://www.facebook.com/groups/167450350489702
#General_function
#illustrated_pathology
#labtechnologist
#medical_student
#Medical_tips
#pathology#disease
#Sojib
© Md Sojib Khan
No comments:
Post a Comment